Levetiracetam, CAS [[102767-28-2]]
Artikelnummer:
MCE-HY-B0106
| Artikelname: |
Levetiracetam, CAS [[102767-28-2]] |
| Artikelnummer: |
MCE-HY-B0106 |
| Hersteller Artikelnummer: |
HY-B0106 |
| Alternativnummer: |
MCE-HY-B0106-500MG,MCE-HY-B0106-10MMX1ML,MCE-HY-B0106-50MG,MCE-HY-B0106-100MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
UCB L059 |
| Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent[1][2]. |
| Molekulargewicht: |
170.212 |
| Reinheit: |
99.98 |
| CAS Nummer: |
[102767-28-2] |
| Formel: |
C8H14N2O2 |
| Target-Kategorie: |
DNA Methyltransferase |
| Anwendungsbeschreibung: |
Reference compound |
